Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
about
The scientific foundation for tobacco harm reduction, 2006-2011E-cigarettes: methodological and ideological issues and research prioritiesElectronic nicotine delivery systems ("e-cigarettes"): review of safety and smoking cessation efficacyNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers)Patterns of tobacco use and dual use in US young adults: the missing link between youth prevention and adult cessation.Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smokingA systematic review of nicotine by inhalation: is there a role for the inhaled route?The long and winding road to inhaled TB therapy: not only the bug's fault.Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System.Acceptability and effectiveness for withdrawal symptom relief of a novel oral nicotine delivery device: a randomised crossover trial.Toxicity of aerosols of nicotine and pyruvic acid (separate and combined) in Sprague-Dawley rats in a 28-day OECD 412 inhalation study and assessment of systems toxicology.Commentary on Wagener et al. (2012): laissez-faire regulation: turning back the clock on the Food and Drug Administration and public health.
P2860
Q27497414-3F9BA6C7-822B-44BA-B9A7-D715CA9EEE0EQ28082075-B8C35946-41D7-4C4D-8716-F63D05390ADEQ28241387-9F44B5AC-CBF4-4C60-93A0-06C936830674Q28277165-55EC3BB2-4D03-4AC6-9AF9-23779AE7E2C3Q34376892-18293DD5-8AE2-4CF3-9DFD-B0087E3B36CCQ35626448-F01CD48D-216C-4F0C-A6A7-7829879D5DA0Q35991046-77641DFD-FE7D-451D-B9BC-78B2852F7830Q36868963-F7D069BB-9D88-49BC-BF81-4803BE92A587Q36929845-E661EF19-B132-4437-9700-663FBEF470AFQ37989379-B9EC7492-0C8F-46F6-96D3-E8E9437442CCQ38782463-B0DC1A2C-2244-4F0C-BF3D-71721DE50BA2Q38798057-92425742-0AAB-4416-87FB-8531C078643DQ39271218-4AB1929B-B332-48C4-B0B1-D065C3D7C8C8Q40620243-6846F1BF-287A-480F-A5BE-3F36EFEC1C18Q49184593-D4FFF28D-C337-494D-804C-24454EEA9ACD
P2860
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@ast
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@en
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@nl
type
label
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@ast
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@en
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@nl
prefLabel
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@ast
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@en
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@nl
P2093
P356
P1476
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics
@en
P2093
Frédérique M Behm
James E Turner
Jed E Rose
Murray Laugesen
Thangaraju Murugesan
P304
P356
10.1037/A0020834
P407
P577
2010-10-01T00:00:00Z